Related Experiment Video
Updated: Mar 17, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells
Rachel A Burga1, Tuongvan Nguyen2, Jane Zulovich2
1Institute for Biomedical Sciences, The George Washington University, Washington, DC, USA; Children's National Health System, Washington, DC, USA.
Abstract:
Natural killer (NK) cells are members of the innate immune system that recognize target cells via activating and inhibitory signals received through cell receptors. Derived from the lymphoid lineage, NK cells are able to produce cytokines and exert a cytotoxic effect on viral infected and malignant cells. It is their unique ability to lyse target cells rapidly and without prior education that renders NK cells a promising effector cell for adoptive cell therapy. However, both viruses and tumors employ evasion strategies to avoid attack by NK cells, which represent biological challenges that need to be harnessed to fully exploit the cytolytic potential of NK cells. Using genetic modification, the function of NK cells can be enhanced to improve their homing, cytolytic activity, in vivo persistence and safety. Examples include gene modification to express chemokine, high-affinity Fc receptor and chimeric antigen receptors, suicide genes and the forced expression of cytokines such as interleukin (IL)-2 and IL-15. Preclinical studies have clearly demonstrated that such approaches are effective in improving NK-cell function, homing and safety. In this review, we summarize the recent advances in the genetic manipulations of NK cells and their application for cellular immunotherapeutic strategies.
Insights
Natural killer (NK) cells offer promising adoptive cell therapy due to their rapid cytotoxic abilities. Genetic modifications enhance NK cell function, overcoming tumor and viral evasion for improved cancer immunotherapy.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Natural killer (NK) cells are crucial innate immune cells with cytotoxic and cytokine-producing capabilities.
- Their ability to rapidly lyse target cells without prior sensitization makes them ideal for adoptive cell therapy.
- Tumors and viruses utilize evasion strategies to escape NK cell-mediated destruction, posing challenges for immunotherapy.
Purpose of the Study:
- To review recent advancements in genetically modifying NK cells.
- To explore strategies for enhancing NK cell function for improved immunotherapy.
- To summarize the application of engineered NK cells in cellular immunotherapy.
Main Methods:
- Genetic modification techniques to enhance NK cell properties.
- Introduction of chemokine, high-affinity Fc receptors, and chimeric antigen receptors.
- Incorporation of suicide genes and forced expression of cytokines like IL-2 and IL-15.
Main Results:
- Preclinical studies demonstrate enhanced NK cell homing, cytolytic activity, and in vivo persistence.
- Genetic engineering improves the safety profile of NK cell-based therapies.
- Engineered NK cells show increased effectiveness against viral infections and malignancies.
Conclusions:
- Genetic manipulation is a powerful tool to optimize NK cell-based immunotherapies.
- Overcoming NK cell evasion strategies is key to fully exploiting their therapeutic potential.
- Advances in NK cell engineering pave the way for novel cellular immunotherapeutic strategies against cancer and viral diseases.
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

